In summary, overactivation of the UPR—and in particular the PERK/eIF2α pathway—appears to be implicated in the pathogenesis of Alzheimer’s disease and related disorders in human patients, and there is compelling evidence for its role in mediating neurodegeneration in preclinical studies. Here, EIF2A is linked to Alzheimer disease.